Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 6;11(11):3224.
doi: 10.3390/jcm11113224.

Hypertriglyceridemia and Other Risk Factors of Chronic Kidney Disease in Type 2 Diabetes: A Hospital-Based Clinic Population in Greece

Affiliations

Hypertriglyceridemia and Other Risk Factors of Chronic Kidney Disease in Type 2 Diabetes: A Hospital-Based Clinic Population in Greece

Ilias N Migdalis et al. J Clin Med. .

Abstract

Aims/introduction: Several reports indicate an increasing prevalence of chronic kidney disease (CKD) in type 2 diabetes mellitus (T2DM). Hyperglycemia and hypertension are the main risk factors for CKD development and progression. However, despite the achievement of recommended targets for blood glucose and blood pressure (BP), the residual risk of diabetic chronic kidney disease (DCKD) remains relatively high. The aim of this study is to examine dyslipidemia and other major risk factors to provide support for the prevention and treatment of DCKD.

Materials and methods: Participants are from the Redit-2-Diag study that examines 1759 subjects within a period of 6 months. DCKD severity is staged according to KDIGO criteria.

Results: An increase in hemoglobin A1c (1 unit) and systolic blood pressure (1 mm Hg) increases the probability of being classified into a higher CKD stage by 14% and 26%, respectively. Moreover, an increase of triglycerides by 88.5 mg/dL increases the risk of classification to a worse CKD stage by 24%.

Conclusions: Elevated triglycerides, systolic blood pressure, and poor glycemic control increase the risk of CKD in T2DM and should be addressed in the treatment strategies.

Keywords: blood pressure; diabetic chronic kidney disease; triglycerides; type 2 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Plasma concentrations of lipid levels in subjects with T2DM and normal kidney function (NKF) or diabetic chronic kidney disease (DCKD). * p < 0.01.
Figure 2
Figure 2
An increase of HbA1c by 1 unit, triglycerides (TG) by 88.5 mg/dL, and systolic blood pressure (SBP) by 1 mm Hg, increased the progression of diabetic chronic kidney disease (DCKD) by 14%, 24%, and 26%, respectively.

Similar articles

Cited by

References

    1. Koye D.N., Magliano D.J., Nelson R.G., Pavkov M.E. The global epidemiology of diabetes and kidney disease. Adv. Chronic Kidney Dis. 2018;25:121–132. doi: 10.1053/j.ackd.2017.10.011. - DOI - PMC - PubMed
    1. Griffin T.P., O’Shea P.M., Smyth A., Islam M.N., Wall D., Ferguson J., O’Sullivan E., Finucane F.M., Dinneen S.F., Dunne F.P., et al. Burden of chronic kidney disease and rapid decline in renal function among adults attending a hospital-based diabetes center in Northern Europe. BMJ Open Diab. Res. Care. 2021;9:e002125. doi: 10.1136/bmjdrc-2021-002125. - DOI - PMC - PubMed
    1. Migdalis I.N., Papanas N., Raptis A.E., Ioannidis I.M., Sotiropoulos A.E., Dimitriadis G.D. The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: A series from hospital-based diabetes clinics. Diabetes Res. Clin. Pract. 2020;11:1–8. doi: 10.1016/j.diabres.2020.108243. - DOI - PubMed
    1. Kovesdy C.P., Isaman D., Petruski-Ivleva N., Fried L., Blankenburg M., Gay A., Velentgas P., Folkerts K. Chronic kidney disease progression among patients with type 2 diabetes identified in US administrative claims: A population cohort study. Clin. Kidney J. 2020;45:1–8. doi: 10.1093/ckj/sfaa200. - DOI - PMC - PubMed
    1. Webster A.C., Nagler E.V., Morton R.L., Masson P. Chronic Kidney Disease. Lancet. 2017;389:1238–1252. doi: 10.1016/S0140-6736(16)32064-5. - DOI - PubMed

LinkOut - more resources